The AMD Center

Case presentation: CSR vs CNV, role of OCTA

Case presentation: RAP lesion and Geographic atrophy

Case presentation: Intraretinal fluid

Case presentation: Type 1 CNV vs CSR

Case presentation: PED

Case presentation: RAP Lesion

Case presentation: OCT Angiography

Injection techniques

Treatment paradigm

Baseline testing

Emerging Treatments for Dry AMD


Demetrios Vavvas, MD, describes his recent talk on emerging treatments for dry age-related macular degeneration (AMD)…

Demetrios Vavvas, MD, PhD

Optimizing Visual Outcomes in Wet AMD

Carl Regillo, MD, talks about his recent presentation on how to optimize visual outcomes in patients with wet age-relate…

Carl D. Regillo, MD, FACS

ASSESS Study - 24 Months

Rishi P. Singh, MD, reviews details of the ASSESS study, which transitioned patients who had previously been treated wit…

Rishi P. Singh, MD

Drug Selection and Patient Outcomes in AMD

David Eichenbaum, MD, demonstrates how drug selection can affect outcomes over time by sharing the cases of two patients…

David Eichenbaum, MD

Potential Treatments for AMD

Thomas Ciulla, MD, describes a study designed to address an unmet need in AMD. Anti-VEGF therapy is very effective in th…

Thomas Ciulla, MD

Displacement of Subfoveal Hemorrhage by Perfluorocarbon

Gurkan Erdogan, MD, presents an age-related macular disease (AMD) case with subretinal hemorrhage in a patient with sudd…

Gurkan Erdogan, MD

UK's Leading Blindness Organizations Meet to Address Macular…

The AMD Alliance International led an event at the House of Commons in January 2015 that addressed the current issues th…

Intraocular Miniature Telescope Lens

Howard Gimbel, MD, presents his technique for placing an intraocular miniature telescope for macular degeneration. This …

Howard Gimbel MD

Case Presentation Wet AMD with RPE Tear

Wet AMD Injection Techniques

Presentation Wet AMD With Macula Hemorrhage

Management of Myopic Choroidal Neovascularization

Professor Tien Yin Wong, MD, PhD shares his view on the management of Myopic Choroidal Neovascularization (myopic CNV), …

Professor Tien Yin Wong, MD, PhD

Management of Myopic Choroidal Neovascularization

Yasushi Ikuno, MD provides his perspective on the management of Myopic Choroidal Neovascularization (myopic CNV), includ…

Yasushi Ikuno, MD

Lower the Burden: Two-Year Efficacy of Stereotactic Radiothe…

Darius Moshfeghi, MD

Screening Patients and Treating with Oraya Therapy

Andre Luff, MA, FRCS, FRCS (Ophth), FRCOphth

Not What You Expect: Identifying and Assessing Microvascular…

Usha Chakravarthy, MD, FRCS, FRCOphth, PhD

Clinical Experience with Intravitreal Aflibercept for Wet AM…

As his amount of clinical experience with aflibercept increases, Arshad M. Khanani, MD, of Sierra Eye Associates, Reno, …

Arshad M. Khanani, MD

Genetic Polymorphisms Predict Response to Antioxidants and Z…

AREDS demonstrated that antioxidants and zinc supplements decreased progression of age-related macular degeneration (AMD…

Carl C. Awh, MD

Wet AMD and Fluid

Wet AMD Case Presentation

Wet AMD Case Presentation

Wet AMD Treatment Paradigm

Important Product Information

Jason S. Slakter, MD

Case 3: Female, 88

W. Lloyd Clark, MD, presents the case study of an 88-year old male with wet AMD that participated in the VIEW 1 trial of…

W. Lloyd Clark, MD

Case 2: Female, 72

W. Lloyd Clark, MD, presents the case study of a 72-year old female with wet AMD that participated in the VIEW 1 trial o…

W. Lloyd Clark, MD

Case 1: Male, 84

W. Lloyd Clark, MD, presents an 84-year old male with wet AMD that participated in the VIEW 1 trial of EYLEA® (afliberc…

W. Lloyd Clark, MD

wAMD Series Introduction

Jason S. Slakter, MD, presents the efficacy and safety findings of the VIEW 1 and VIEW 2 trials of EYLEA® (aflibercept)…

Jason S. Slakter, MD, W. Lloyd Clark, MD

Latest Observations on Wide-Field Imaging of Retinal Disease…

Szilárd Kiss, MD, an assistant professor of ophthalmology at Weill Cornell Medical College in New York, provides an upd…

Szilard Kiss, MD, Timothy G. Murray MD, MBA, FACS

Nothing in Vein: the Evolving Management of Retinal Venous O…

Julia A. Haller, MD, professor of ophthalmology at Jefferson University Hospitals in Philadelphia, discusses the evolvin…

Julia Haller MD, Timothy G. Murray MD, MBA, FACS

Anti-VEGF Maintenance Therapy for Neovascular AMD

Carl D. Regillo, MD, FACS, of Wills Eye in Philadelphia discusses using anti-VEGF for maintenance therapy in patients w…

Carl Regillo, MD, Timothy G. Murray MD, MBA, FACS

Systemic Levels of Anti-VEGF: What Available Data Reveal

Robert L. Avery, MD, discusses the recent finding from CATT, IVAN on systemic concentrations of bevacizumab and ranibizu…

Robert Avery MD, PhD

RPE Transplantation for Dry AMD

Carl Claes, MD

Case Presentation Wet AMD

Alex P. Hunyor, MB, BS, FRANZCO, FRACS, Kourous A. Rezaei MD, Som Prasad MS FRCSEd, Yusuke Oshima, MD

Treatment Paradigm for Wet AMD: Australia, United Kingdom, a…

Alex P. Hunyor, MB, BS, FRANZCO, FRACS, Kourous A. Rezaei MD, Som Prasad MS FRCSEd, Yusuke Oshima, MD

Intravitreal injection techniques: Australia, United Kingdom…

Alex P. Hunyor, MB, BS, FRANZCO, FRACS, Kourous A. Rezaei MD, Som Prasad MS FRCSEd, Yusuke Oshima, MD

CNV for AMD

This video shows a case of CNV in AMD. A process of steps are taken where the retina is detached by injection. The retin…

Barbara Parolini, MD

ROP and Avastin

Carl Claes, MD

Twenty-five Gauge Vitretctomy for TRD and RRD Repair

The 25-gauge vitrector is utilized to repair this combined TRD and RRD. The retina is very thin, ischemic and mobile. Th…

Maria H. Berrocal, MD

A Clinical Understanding of Anti-VEGF Therapy in AMD

Richard F. Spaide, MD, provides an overview of neovascular age-related macular degeneration and the various therapies th…

Richard Spaide, MD

Two-Year Outcomes in the IVAN Trial

Usha Chakravarthy, MD, FRCS, FRCOphth, PhD, explains the results of a 24-month trial that investigated the differences b…

Usha Chakravarthy, MD, FRCS, FRCOphth, PhD

Results of the AREDS 2 Study

Srinivas R. Sadda, MD, shares the results of the AREDS 2 Study, which tested an updated formulation of the AREDS nutriti…

SriniVas Sadda, MD

Effects of Switching AMD Patients to Aflibercept

Ted Leng, MD, reviews the visual acuity and anatomic outcomes of eyes with age-related macular degeneration that were sw…

Ted Leng, MD

HARBOR 2 Results Support Individualized Dosing in Patients w…

Brandon Busbee, MD, discusses the HARBOR 2 study results, focusing on how the results support individualized dosing in p…

Brandon G. Busbee, MD

Implantation of Intraocular Mirror Telescope Implant as Ante…

Isaac Lipshitz, MD, evaluated the efficacy of a newly designed mirror telescopic implant (X2.5 Mag) for improving the vi…

Isaac Lipshitz, MD

Endpoint Management and PASCAL Laser Systems: Less-Damaging …

Pravin Dugel, MD, ophthalmologist at Retinal Consultants of Arizona, discusses the shift in the use of lasers for the tr…

Pravin U. Dugel MD

Wet AMD Case Presentation II

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Wet AMD Case Presentation III

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Wet AMD Case Presentation I

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Treatment Patterns for wet AMD

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Intravitreal Injections IV

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Intravitreal Injections III

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Intravitreal Injections II

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Intravitreal Injections I

Moderator: Kourous Rezaei, MD Panel: Bob Avery, MD, Jay S. Duker, MD, SriniVas Sadda, MD

Are multifocal IOLs contraindicated in AMD?

During the session on cataract surgery and macular disease held earlier today, Jean-François Korobelnik, MD, reviewed t…

Jean-François Korobelnik, MD

Foresee Preferential Hyperacuity Perimeter in Clinical Pract…

Paul Garfinkle, MD, discusses PHP (Preferential Hyperacuity Perimeter) in clinical practice as strategy for early detect…

Results of the LEVEL Study

The LEVEL Study assessed the efficacy of Macugen (pegaptanib sodium injection) as maintenance therapy in neovascular age…

Thomas Friberg MD

Pharmacosurgery with the Intrector

Vitreo-Retinal pharmacosurgery with Intrector is the newest step for intravitreal combination therapy. In this video, Dr…

Frank Koch MD

InVitria: Intravitreal Injection Assistant

The InVitria (Medical Workshop, The Netherlands) is a disposable device for simplifying intravitreal injections and is d…

Arnaldo Gonçalves MD

Implantation of a Free Transplant of RPE and Choroid for Wet…

Bernd Kirchof, MD, presents a RPE transplantation in a retinotomy case and a complex case when a diamond blade cuts thro…

Bernd Kirchof MD

Significance of Mature Abnormal Vessels in the Treatment of …

Indication Visudyne® is indicated for the treatment of predominantly classic subfoveal choroidal neovascularization …

Mark S. Hughes MD

Challenges in the Management of AMD

Julia Haller, MD discusses the treatment of age-related macular degeneration (AMD).

Julia Haller MD

Implementing Intravitreal Injections in Clinical Practice

Nancy Holekamp, MD provides an overview of intravitreal injections in AMD management and shares her approach to incorpor…

Nancy Holekamp MD

SAILOR Cohort 1 Results

Dr. Boyer discusses the SAILOR cohort 1 results which evaluated safety, efficacy, and tolerability of intravitreal treat…

David Boyer MD

Vision-Related Function After Ranibizumab Treatment From ANC…

Dr. Bressler discusses the effects of ranibizumab treatments on visual acuity and patient's perception of improvemen…

Neil Bressler MD

Part II

Part I

AAO - 2007 Symposium: Implementing New Data to Treat the AMD Patient

LUCENTIS (Ranibizumab Injection) Overview

A comprehensive overview of LUCENTIS (Ranibizumab Injection)